Introduction: Who Should Undergo Diagnostics

Patients who have an arteriovenous graft, which is a soft synthetic tube placed between an artery and a vein to allow hemodialysis, should undergo regular monitoring and diagnostic assessments. These grafts are typically implanted in people with severe kidney disease who require routine dialysis to remove waste and excess fluids from their blood. The graft provides a reliable access point where dialysis needles can be inserted multiple times each week.^[1]

If you have an arteriovenous graft, you should seek diagnostic evaluation whenever you notice changes in how your graft feels or functions. More than 400,000 patients in the United States depend on hemodialysis, and problems with arteriovenous grafts can lead to missed dialysis sessions, hospital admissions, and the need for temporary dialysis catheters inserted into large veins. Since graft complications can prevent successful dialysis and increase risks of infections and other serious problems, early detection through proper diagnostics is crucial.^[5][8]

Diagnostics are particularly important when you experience difficulties during dialysis sessions, such as problems with blood flow through the graft, prolonged bleeding after needle removal, or pain in the graft area. Regular monitoring helps identify problems before complete blockage occurs, potentially avoiding emergency situations that require more invasive treatments.^[4]

Diagnostic Methods for Identifying Graft Problems

Physical Examination: Look, Feel, and Listen

The most basic and frequently used diagnostic method involves a focused physical examination of your arteriovenous graft. Healthcare providers use what is called the “look, feel, and listen” approach, which should be performed at least monthly by a qualified practitioner. This simple but effective examination can identify many problems that affect the graft, including narrowing of blood vessels, bulging areas called aneurysms, infections, and reduced blood flow.^[5][8]

During the “look” portion of the examination, the doctor or nurse visually inspects your graft and the surrounding skin for signs of swelling, redness, bulging veins, or other unusual changes. The skin over a healthy graft appears normal, while problems may cause visible swelling in your arm or leg, or purplish bulging veins similar to varicose veins.^[2]

The “feel” component involves palpating, or touching, the graft to check for what is called a thrill. A thrill is a slight vibration you can feel when you put your fingers on the skin over the graft, caused by blood rushing through the connection between the artery and vein. You should always be able to feel this vibration, which is sometimes also described as a pulse. If the thrill disappears or becomes very weak, it may indicate that blood flow has slowed or stopped due to narrowing or clot formation.^[5][12]

Checking for changes in how the thrill feels provides important clues about where problems might be located. Increased pulsatility, meaning the graft feels more like it is pulsing strongly rather than vibrating smoothly, may signal narrowing in the vein that carries blood away from the graft. This is called outflow stenosis. In contrast, decreased or weakened pulsation might indicate narrowing on the artery side, known as inflow stenosis.^[8][12]

The “listen” portion uses a stethoscope or Doppler device to hear the sound of blood flowing through your graft. Normal grafts produce a characteristic sound called a bruit, which results from turbulent blood flow through the circuit. When a graft is narrowing, the bruit may sound different than usual, sometimes becoming high pitched or lacking certain sound components that would normally be present throughout the heartbeat cycle. A flat fistula with poor turgor or a weak bruit suggests problems with blood flow into the graft.^[8][12]

Arm Elevation Test

A simple clinical test called the arm elevation test can help identify narrowing in the veins that drain blood from your graft. To perform this test, you hold your arm with the graft above your heart for a period of time. Normally, the examiner should see the fistula collapse as blood drains away, except in rare cases where blood flow is extremely high. If narrowing is present in the outflow vein, the graft will collapse in the area closer to your heart because blood cannot flow back properly through the narrowed segment. This test provides a quick way to detect problems without requiring complex equipment.^[8]

Duplex Ultrasound

Duplex ultrasound is an imaging technique that uses sound waves to create pictures of blood vessels and measure blood flow. This test is relatively easy to perform on grafts located near the skin surface and provides valuable information to complement physical examination findings. During the test, a technician moves a hand-held device called a transducer over the skin where your graft is located. The ultrasound can detect narrowing that might not be obvious during simple clinical evaluation, even when physical examination appears normal.^[1]

Ultrasound can also be used during the creation of an arteriovenous graft to evaluate blood vessels beforehand. This is called preoperative vascular mapping, and it helps surgeons choose the best arteries and veins to connect. The test measures the size of blood vessels and assesses blood flow to ensure adequate circulation. Studies have shown that when access flow is measured repeatedly over time using ultrasound, trends of decreasing flow can predict the development of narrowing before thrombosis occurs.^[1][4]

While routine screening with ultrasound is not currently standard practice for all patients with grafts that are working normally, there is evidence that using ultrasound to evaluate grafts showing clinical signs of dysfunction could help maintain better long-term function and prevent complications.^[8]

Review of Dialysis Treatment Data

Information collected during your regular dialysis sessions can serve as an important diagnostic tool. Healthcare providers review data such as Kt/V, serum potassium levels, pump pressures, and any problems with inserting needles into the graft. Kt/V is a measurement that quantifies how well your dialysis is working. The “K” represents the clearance of urea, a waste product, “t” represents the time spent on dialysis, and “V” represents the volume of fluid in your body. Changes in these measurements can indicate problems with your graft before you notice any symptoms.^[5][12]

Other warning signs detected during dialysis include prolonged bleeding after dialysis needles are removed, difficulty inserting needles into the usual access points, or inadequate blood flow rates during treatment. These problems may suggest that narrowing has developed in the graft or connected blood vessels.^[5]

Angiography

Angiography is an imaging test that provides detailed pictures of blood vessels by injecting a special dye, called contrast material, into the graft and taking X-ray images. This test allows doctors to see the exact location and severity of any narrowing or blockage. Angiography is typically performed when physical examination, ultrasound, or dialysis data suggest a problem that may require treatment. The test is done in a specialized radiology suite and involves inserting a thin tube called a catheter into the graft to deliver the contrast material and capture images as blood flows through the vessels.^[6]

Although angiography provides the most detailed visualization of the graft and connected blood vessels, it is an invasive procedure that carries some risks. For this reason, it is usually reserved for situations where treatment is likely to be needed, rather than being used as a routine screening tool.^[6]

Blood Flow Measurement in the Operating Room

When an arteriovenous graft is first created during surgery, blood flow is assessed immediately after the surgeon connects the graft to your artery and vein. Historically, surgeons evaluated the graft by feeling for a palpable thrill after restoring blood flow. A good thrill indicates adequate flow through the graft, and gently pressing on the vein while feeling for a pulse confirms proper connection. If no thrill can be felt, it may indicate a problem downstream that blocks blood flow.^[1]

Some surgical centers also use duplex ultrasound in the operating room to measure blood flow immediately after creating the graft. This provides objective measurements to confirm that the graft is functioning properly before completing the surgery.^[1]

Diagnostics for Clinical Trial Qualification

When patients with arteriovenous graft thrombosis are being considered for enrollment in clinical trials testing new treatments, specific diagnostic criteria are used to determine eligibility. While the exact requirements vary depending on the particular trial, certain tests and measurements are commonly used as standard criteria.^[7]

Clinical trials typically require confirmation that thrombosis has actually occurred in the graft. This is usually established through a combination of clinical examination and imaging studies. Physical examination findings that suggest thrombosis include absence of the normal thrill or pulse when palpating the graft, inability to perform dialysis due to inadequate blood flow, or visible clotting within the graft. Ultrasound imaging provides definitive confirmation by showing static blood within the graft that is not flowing, or by detecting the presence of clot material within the vessel.^[5][7]

Trials may also establish time criteria, such as requiring that the thrombosis occurred within a certain number of hours or days before enrollment. This ensures that treatments being tested are applied at consistent time points after clot formation. Angiography is frequently performed as part of trial protocols to document the exact location and extent of thrombosis and to identify any underlying narrowing that may have caused the clot to form.^[6]

Additional eligibility criteria often include verification that the patient’s overall health status is stable enough to participate in the trial. This may involve blood tests to check kidney function, blood counts, and clotting parameters. Trials testing specific treatment approaches, such as catheter-based clot removal techniques or clot-dissolving medications, may have additional requirements related to the size and location of the graft or the extent of thrombosis.^[3][9]

Some clinical trials may require evidence that the thrombosis resulted from narrowing or stenosis rather than other causes. This typically involves angiography to visualize the blood vessels and identify areas where the vessel diameter has decreased. The presence and severity of stenosis can be quantified by measuring the percentage of narrowing compared to the normal vessel diameter. Trials may specify minimum or maximum degrees of stenosis for inclusion.^[4]

Contraindications for trial enrollment are also established through diagnostic evaluation. Patients may be excluded if imaging reveals certain high-risk features, if blood tests show clotting disorders that increase bleeding risk during treatment, or if physical examination suggests active infection at the graft site. Pregnancy testing may be required for women of childbearing age, as some trial treatments might pose risks to a developing fetus.^[3]

Patient Self-Monitoring

An important aspect of graft care involves teaching patients to perform their own daily examinations. Patients are instructed to check their graft each day to become familiar with how a healthy thrill feels and to look for any redness, swelling, or other changes that might indicate an infection or other problem. Recognizing changes early allows patients to contact their healthcare team promptly, which can expedite treatment and potentially save the graft while avoiding the need for surgery or temporary catheter placement.^[8]

Patients learn to feel for the characteristic vibration or pulse in their graft and become alert to situations where this sensation weakens or disappears. They are also taught to watch for signs such as increased swelling, pain, warmth, or drainage from the surgical site. This self-monitoring complements formal medical evaluations and provides continuous surveillance between scheduled healthcare visits.^[15]